Stephen Ollosi

Stephen Ollosi is currently the Associate Director of Molecular Biology at Advanced Medicine Partners and the Associate Director of Analytical Development at Jaguar Gene Therapy. With previous experience at AveXis, Inc. and Loyola University Chicago, Stephen has a strong background in molecular biology and biochemistry. Their thesis at Loyola University Chicago focused on investigating the role of Endothelin-1 signaling in NSCLC disease progression and neo-angiogenesis. Stephen's expertise includes optimizing in vitro assays, animal handling, and data analysis, making them a valuable asset in the field of molecular biology.